Haloperidol Laropharm 0.5mg Tablets Malta - English - Medicines Authority

haloperidol laropharm 0.5mg tablets

farmarosib srl 193 stefan cel mare street, sibiu, romania - haloperidol - tablet - haloperidol 0.5 mg - psycholeptics

PERSKINDOL CLASSIC GEL Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

perskindol classic gel

zuellig pharma sdn bhd - levomenthol (menthol); oil of pine; orange oil; wintergreen oil; bergamot oil; lemon oil; terpineol; terpinyl acetate; rosemary oil; lavender oil -

PERSKINDOL CLASSIC GEL Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

perskindol classic gel

zuellig pharma sdn bhd - levomenthol (menthol); oil of pine; orange oil; wintergreen oil; bergamot oil; lemon oil; terpineol; terpinyl acetate; rosemary oil; lavender oil -

Imprida HCT European Union - English - EMA (European Medicines Agency)

imprida hct

novartis europharm ltd. - amlodipine, valsartan, hydrochlorothiazide - hypertension - angiotensin ii antagonists, plain, angiotensin ii antagonists, combinations - treatment of essential hypertension as substitution therapy in adult patients whose blood pressure is adequately controlled on the combination of amlodipine, valsartan and hydrochlorothiazide (hct), taken either as three single-component formulations or as a dual-component and a single-component formulation.

Tekturna European Union - English - EMA (European Medicines Agency)

tekturna

novartis europharm ltd. - aliskiren - hypertension - agents acting on the renin-angiotensin system - treatment of essential hypertension

Enviage European Union - English - EMA (European Medicines Agency)

enviage

novartis europharm ltd. - aliskiren - hypertension - agents acting on the renin-angiotensin system - treatment of essential hypertension

Trazec European Union - English - EMA (European Medicines Agency)

trazec

novartis europharm ltd. - nateglinide - diabetes mellitus, type 2 - drugs used in diabetes - nateglinide is indicated for combination therapy with metformin in type 2 diabetic patients inadequately controlled despite a maximally tolerated dose of metformin alone.